Long-term use of interferon-β in multiple sclerosis increases Vδ1 - Vδ2 - Vγ9 - γδ T cells that are...
Long-term use of interferon-β in multiple sclerosis increases Vδ1 - Vδ2 - Vγ9 - γδ T cells that are associated with a better outcome
About this item
Full title
Author / Creator
Publisher
England: BioMed Central
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central
Subjects
More information
Scope and Contents
Contents
We previously reported that Vδ2
Vγ9
γδ T cells were significantly decreased in multiple sclerosis (MS) patients without disease-modifying therapies (untreated MS) and were negatively correlated with Expanded Disability Status Scale (EDSS) scores, suggesting protective roles of Vδ2
Vγ9
γδ T cells. Interferon-β (IFN-β) is one of the first...
Alternative Titles
Full title
Long-term use of interferon-β in multiple sclerosis increases Vδ1 - Vδ2 - Vγ9 - γδ T cells that are associated with a better outcome
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ce6e9f698717401ab1d341926977e6a9
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ce6e9f698717401ab1d341926977e6a9
Other Identifiers
ISSN
1742-2094
E-ISSN
1742-2094
DOI
10.1186/s12974-019-1574-5
